STOCK TITAN
  1. Home
  2. IMMNOV

IMMNOV Stock Price, News & Analysis

IMMNOV
Published by Stock Titan Data refreshed

What Changed

Company Description

This page collects what Stock Titan holds for IMMNOV, including price data and latest news.

Stock Performance

Chart
—
-
-
-
Performance 1 year
-
Market Cap
-
Shares outstanding

Latest News

View All
—

Immunovia publishes the Annual Report for 2024

—

Immunovia provides further positive data from the VERIFI study of its next-generation pancreatic cancer test

—

Immunovia to host a webcast to share more data from the successful VERIFI clinical validation study

conferences
—

Immunovia announces another successful clinical validation of its next-generation pancreatic cancer test

—

Immunovia's CLARITI study results selected for prestigious presentation at the world's largest gastroenterology conference

—

Immunovia initiates search for a new CFO to support commercialization in the USA

—

Immunovia AB (Publ) presents Nomination Committee

—

Immunovia discovery study published in top protein research journal

—

End of the Year 2024 Letter from Immunovia CEO Jeff Borcherding

—

Immunovia CEO and board members announce intention to fully exercise their TO2 warrants

offering management

IMMNOV has 10 recent news articles. Key topics include conferences, offering, management. View all IMMNOV news →

SEC Filings

No SEC filings available for IMMNOV.